<\/p>\n
Hims & Hers, a direct-to-consumer telehealth provider, has launched an AI care agent<\/a> that aims to help users understand and engage with their laboratory results.<\/p>\n Called Labs AI, the agent is embedded in the Hims & Hers platform and delivers personalized insights on users’ lab results. Some users already have access to Labs AI, though the company did not provide a timeline for widespread access to the tool.<\/p>\n According to the company, the agent analyzes trends in users’ biomarkers<\/a> from lab tests, which are objective measures that provide information about cells or organisms. The agent is trained to identify patterns across 130-plus biomarker tests. It creates a profile for each user that shows current and historical biomarker values, trends over time and demographic and lifestyle information. The profile also includes prior care notes, if a user chooses to share them.<\/p>\n The advantage of this approach is that the AI can pinpoint patterns that cannot be gleaned from a single biomarker, the company stated.<\/p>\n Further, users can discuss their biomarkers and other analytics with Labs AI. The agent, which combines\u00a0frontier language models<\/a> with Hims & Hers’ clinical knowledge base, shares responses from a curated database of clinical information and protocols.\u00a0<\/p>\n The company also emphasized the guardrails that ensure the safe use of its new AI agent. These include automated evaluations for accuracy and regression-testing performance against fixed benchmarks set by medical experts when protocols change.\u00a0<\/p>\n In addition, the agent is trained to escalate care to human clinicians when needed. The company underscored that the agent “never diagnoses,” rather connecting users with providers via the Hims & Hers telehealth platform.<\/p>\n “Trust has to be earned in healthcare, which is why Labs AI was built with clinicians and evaluated for safety, accuracy, and reliability,” Hims & Hers CMO Pat Carroll, M.D., said in the press release. “We are delivering clearer, more personalized health insights while keeping clinicians accessible to help customers manage their health with confidence.”<\/p>\n The company indicated that this is the first of several new AI tools, calling this launch a “preview” of the AI ecosystem it is planning. According to the press release, the company’s goal is to build AI features and capabilities into its infrastructure rather than layer them on top.<\/p>\n Hims & Hers’ turn to AI development comes as AI becomes increasingly critical for digital health players. With digital health funding ticking up<\/a>, a recent Rock Health report noted AI has become a core component of digital health solutions.\u00a0The report further stated that complex, workflow-embedded use cases are driving funding for AI-based digital healthcare.<\/p>\n